Carol Cruzan Morton

News

Intratumoral Dendritic Cell Therapy Shows Promise in Early-Stage ERBB2-Positive Breast Cancer

Author:: Carol Cruzan Morton

Publish date: December 9, 2024

Participants in a new study received intratumoral cDC1 injections weekly for 6 weeks at two dose levels.

News

Study documents obesity-related defecation disorders

Author:: Carol Cruzan Morton

Publish date: August 14, 2023

“These results support the notion that rectal evacuation disorder/incomplete evacuation may be an important underlying mechanism for fecal incontin...

News

Bulevirtide shows promise in chronic hepatitis D

Author:: Carol Cruzan Morton

Publish date: August 14, 2023

There is no approved treatment for a hepatitis D virus infection which affects between 10 and 20 million people worldwide.